Digital health and mobility assessment

Most active in this area

• FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA

  Barcelona-based global health institute specializing in how environmental exposures — air pollution, chemicals, urban design — affect human health from pregnancy through aging.

  “MOBILISE-D (digital mobility outcomes), sensor-based monitoring in multiple projects, and data linkage work in HELICAL and EUCAN-Connect show growing investment in digital health tools.”

  ES56 projects
• UNIVERSITA DEGLI STUDI DI SASSARI

  Sardinian university combining embedded AI, drone technologies, and sustainable agriculture research with strong African and Mediterranean field expertise.

  “Participation in MOBILISE-D, a large IMI-style project connecting digital mobility measurement to clinical outcomes for ageing, COPD, and hip fracture recovery.”

  IT26 projects
• TEVA PHARMACEUTICAL INDUSTRIES LIMITED

  Global pharma company contributing CNS therapeutics expertise, clinical datasets, and pharmacovigilance to large European health research consortia.

  “MOBILISE-D develops digital mobility outcomes for regulatory endorsement; Trials@Home explores remote clinical trial infrastructure.”

  IL11 projects
• GRUNENTHAL GMBH

  German pharmaceutical company specializing in pain therapeutics, contributing drug discovery, clinical expertise, and digital health capabilities to EU pain research consortia.

  “MOBILISE-D connects digital mobility biomarkers to clinical outcomes across COPD, Parkinson's, and MS populations; Gravitate-Health builds digital tools for medication self-management.”

  DE7 projects
• AMGEN

  Global biopharma company contributing oncology, regulatory science, and real-world data expertise to large European health research partnerships.

  “MOBILISE-D connects digital mobility biomarkers to clinical outcomes for regulatory acceptance — a new direction for Amgen's portfolio.”

  BE6 projects